The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Cited by (308)

Items 201–300 of 308

1. PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer
   Michelle Palmieri, Bruno Catimel, Dmitri Mouradov, Anuratha Sakthianandeswaren, Eugene A. Kapp, Ching‐Seng Ang, Nicholas A. Williamson, Cameron J. Nowell, Michael Christie, Jayesh Desai et al. · 2023 · Molecular & Cellular Proteomics
2. Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro : A 3D Tumour Model for Pre-therapeutic Drug Screening
   Dominik Sebastian Nörz, Christina Susanne Mullins, Daniel J. Smit, Michael Linnebacher, Grith Hagel, Alp Mirdogan, JACQUELINE SIEKIERA, Patrick A. H. Ehm, Jakob Robert Izbicki, Andreas Block et al. · 2021 · Anticancer Research
3. Effects of Vanadyl Complexes with Acetylacetonate Derivatives on Non-Tumor and Tumor Cell Lines
   Valentina Boscaro, Alessandro Barge, Annamaria Deagostino, Elena Maria Ghibaudi, Enzo Laurenti, Domenica Marabello, Eliano Diana, Margherita Gallicchio · 2021 · Molecules
4. Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
   Elisa Mariella, Gaia Grasso, Martina Miotto, Kristi Buzo, Nicole Megan Reilly, Pietro Andrei, Pietro Paolo Vitiello, Giovanni Crisafulli, Sabrina Arena, Giuseppe Rospo et al. · 2024 · Molecular Oncology
5. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants
   Shu-Yi Chen, Jing Gu, Kaichun Wu, Xiaodi Zhao, Yuanyuan Lu · 2024 · Cancer Biology and Medicine
6. A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells
   Gabriele Picco, Consalvo Petti, Livio Trusolino, Andrea Bertotti, Enzo Médico · 2015 · Scientific Reports
7. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy
   Gang Wang, Junjie Wang, Peihao Yin, Ke Xu, Yu‐Zhu Wang, Feng Shi, Jing Gao, Xingli Fu · 2018 · Journal of Cellular Physiology
8. Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions
   Anna Siskova, Jan Král, Jana Drabova, Klára Červená, Kristýna Tomášová, Jiri Jungwirth, Tomáš Hucl, Pavel Kohout, Sandra Summerova, Ľudmila Vodičková et al. · 2022 · International Journal of Molecular Sciences
9. Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
   Valeria Internò, Marco Tucci, Gaetano Pezzicoli, Franco Silvestris, Camillo Porta, Francesco Mannavola · 2020 · Frontiers in Oncology
10. Epigenetically Downregulated Breast Cancer Gene 2 through Acetyltransferase Lysine Acetyltransferase 2B Increases the Sensitivity of Colorectal Cancer to Olaparib
    Siche Chen, Heike Allgayer · 2023 · Cancers
11. Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
    Giorgio Corti, Kristi Buzo, Enrico Berrino, Martina Miotto, Maria Costanza Aquilano, Marilena Lentini, Sara E. Bellomo, Annalisa Lorenzato, Alice Bartolini, Gianluca Mauri et al. · 2024 · npj Precision Oncology
12. Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer
    Yusuke Kobayashi, Kensuke Kumamoto, Hirokazu Okayama, Takuro Matsumoto, Hiroshi Nakano, Katsuharu Saito, Yoshiko Matsumoto, Eisei Endo, Yasuyuki Kanke, Yohei Watanabe et al. · 2021 · PLoS ONE
13. Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis
    Zijing Li, William Pat Fong, Dong‐Sheng Zhang, Hui Luo, Dongliang Chen, Yanyu Cai, Zhigang Chen, Jian-Li Duan, Zi-Yao Huang, Yuting Lu et al. · 2024 · npj Precision Oncology
14. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
    Hee Kyung Kim, In‐Kyoung Lee, Seung Tae Kim, Jeeyun Lee, Kyoung‐Mee Kim, Joon Oh Park, Won Ki Kang · 2019 · Scientific Reports
15. Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer
    Christopher K. McCann, Anna Matveeva, Katherine Ann McAllister, Sandra Van Schaeybroeck, Tamas Sessler, Michael W. Fichtner, Steven Carberry, Markus Rehm, Jochen H.M. Prehn, Daniel B. Longley · 2021 · FEBS Journal
16. The oncogenic roles of NTRK fusions and methods of molecular diagnosis
    Erfan Aref‐Eshghi, Fumin Lin, Marilyn M. Li, Yiming Zhong · 2021 · Cancer Genetics
17. Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
    Giulia Bon, Rossella Loria, Carla Azzurra Amoreo, Alessandra Verdina, Isabella Sperduti, Arianna Mastrofrancesco, Silvia Soddu, Maria Grazia Diodoro, Marcella Mottolese, Matilde Todaro et al. · 2016 · Oncotarget
18. Gastrointestinal tract, its pathophysiology and in-vitro models: A “quick” reference guide to translational studies
    Kristijan Skok, Boštjan Vihar, Uroš Maver, Lidija Gradišnik, Konstantin Bräutigam, Martin Trapečar, Pavel Skok · 2025 · World Journal of Gastroenterology
19. Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models
    Peyton C. High, Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana, Yukimatsu Toh, Kendra S. Carmon · 2025 · Cell Reports Medicine
20. Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the EPHA2-PARD3 axis as a cancer vulnerability in KRAS-mutant colorectal cancer
    Daigo Gunji, Ryohei Narumi, Satoshi Muraoka, Junko Isoyama, Narumi Ikemoto, Mimiko Ishida, Takeshi Tomonaga, Yoshiharu Sakai, Kazutaka Obama, Jun Adachi · 2023 · Molecular Omics
21. Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer
    Carlos Bonilla, Paola Montenegro, Juan Manuel O’Connor, O. Hernando, Enrique Aranda, José Pinto-Llerena, Alejandra Llontop, Jorge Gallardo Escobar, M.D.C. Diaz Romero, Yicel Bautista-Hernández et al. · 2023 · Cancers
22. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy
    Joseph Kim, Dong‐In Koh, Minki Lee, Yoon Sun Park, Seungwoo Hong, Jae-Sik Shin, Mi So Lee, Min-Hwa Kim, Jun Hyung Lee, Joonyee Jeong et al. · 2023 · Cell Death and Differentiation
23. Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
    Elisa Fontana, Gift Nyamundanda, David Cunningham, Dongsheng Tu, Maggie C.U. Cheang, Derek J. Jonker, Lillian L. Siu, Francesco Sclafani, Katherine Eason, Chanthirika Ragulan et al. · 2020 · JCO Precision Oncology
24. A dual-targeted molecular therapy of PP242 and cetuximab plays an anti-tumor effect through EGFR downstream signaling pathways in colorectal cancer
    Linghui Kong, Qun Zhang, Jialei Mao, Lei Cheng, Xiao Shi, Lixia Yu, Jing Ying Hu, Mi Yang, Li Li, Baorui Liu et al. · 2021 · Journal of Gastrointestinal Oncology
25. SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancer
    Takuro Matsumoto, Hirokazu Okayama, Shotaro Nakajima, Katsuharu Saito, Misato Ito, Akinao Kaneta, Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Shotaro Fujita et al. · 2021 · British Journal of Cancer
26. Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
    Hyo‐Jeong Lee, Yeongyu Moon, Jungil Choi, Jeong‐Doo Heo, Sekwang Kim, Hari Krishna Nallapaneni, Young‐Won Chin, Jong‐Kook Lee, Sun‐Young Han · 2022 · Biomolecules & Therapeutics
27. Feedback regulation between histone H3 lysine 18 lactylation and TROP2‐mediated glycolysis drives metastatic progression of colorectal cancer
    Weifeng Wang, Yuxiang Deng, Weihao Li, Ruowei Wang, Chi Zhou, Yanbo Xu, Jiahua He, Le' en Liao, Jin Lan, Long Yu et al. · 2026 · Clinical and Translational Medicine
28. Patient-derived rectal cancer organoids—applications in basic and translational cancer research
    Yumeng Yan, Io Hong Cheong, Peizhan Chen, Xiaoguang Li, Xianli Wang, Hui Wang · 2022 · Frontiers in Oncology
29. Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
    Ian Y. Luk, Jennifer K. Mooi, Dmitri Mouradov, Tao Tan, Cameron M. Scott, Fiona J.M. Chionh, Laura J. Jenkins, Camilla M. Reehorst, Rebecca Nightingale, Peter Stephen Savas et al. · 2025 · Communications Biology
30. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer
    Anthony D. Fischer, Daniel Veronese-Paniagua, Shriya Swaminathan, Hajime Kashima, Deborah C. Rubin, Blair Madison · 2023 · American Journal of Physiology-Gastrointestinal and Liver Physiology
31. Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy
    Leslie Elsner, Lisanne Heimann, Anja Geisler, Babette Dieringer, Klaus-Peter Knoch, Luisa Hinze, Karin Klingel, Michele Solimena, Jens Kurreck, Henry Fechner · 2024 · Biological Procedures Online
32. Hidden patterns of gene expression provide prognostic insight for colorectal cancer
    Dongsan Kim, Kwang‐Hyun Cho · 2022 · Cancer Gene Therapy
33. Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer Samples into Molecular Subtypes
    Chanthirika Ragulan, Katherine Eason, Elisa Fontana, Gift Nyamundanda, Yatish Patil, Pawan Poudel, Rita Teresa Lawlor, Maguy Del Rio, Si‐Lin Koo, Wah Siew Tan et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
34. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
    Marta Falcinelli, Giulia Dell’Omo, Elena Grassi, Elisa Mariella, Simonetta Maria Leto, Sharon Scardellato, Annalisa Lorenzato, Sabrina Arena, Andrea Bertotti, Livio Trusolino et al. · 2023 · Cell Death and Disease
35. Proteomic profiling and network biology of colorectal cancer liver metastasis
    Rubén A. Bartolomé, José Ignacio Casal · 2023 · Expert Review of Proteomics
36. Predictive “omic” biomarkers of drug response: Colorectal cancer as a model
    Enrico Mini, Ida Landini, Antonello Di Paolo, Gloria Ravegnini, Simona Saponara, Maria Frosini, Andrea Lapucci, Stefania Nobili · 2022 · Elsevier eBooks
37. Tumor microenvironment-mimicking macrophage nanovesicles as a targeted therapy platform for colorectal cancer
    Edoardo D’Angelo, Riccardo Rampado, Francesca Sensi, Asia Marangio, Anna De Rossi, Ombretta Repetto, Agostino Steffan, Diana Corallo, Sanja Aveic, Gaia Bianchi et al. · 2025 · International Journal of Pharmaceutics
38. Metabolic Response to Small Molecule Therapy in Colorectal Cancer Tracked with Raman Spectroscopy and Metabolomics
    Gabriel Cutshaw, Neeraj Joshi, Xiaona Wen, Elizabeth Quam, Galina T. Bogatcheva, Nora Ali Hassan, Saji Uthaman, Joshua R. Waite, Soumik Sarkar, Bhuminder Singh et al. · 2024 · Angewandte Chemie
39. First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
    Marco Airoldi, Michela Bartolini, Roberta Fazio, Sara Farinatti, Valentina Daprà, Armando Santoro, Alberto Puccini · 2024 · Current Oncology Reports
40. Time- and Zinc-Related Changes in Biomechanical Properties of Human Colorectal Cancer Cells Examined by Atomic Force Microscopy
    Maria Maares, Claudia Keil, Leif Löher, Andreas Weber, Amsatou Andorfer-Sarr, Hajo Haase, Jagoba J. Iturri, José Luis Toca-Herrera · 2020 · Biology
41. The association between ERK inhibitor sensitivity and molecular characteristics in colorectal cancer
    Hodaka Tayama, Hideaki Karasawa, Akihiro Yamamura, Yasunobu Okamura, Fumiki Katsuoka, Hideyuki Suzuki, Taiki Kajiwara, Minoru Kobayashi, Yuuri Hatsuzawa, Masahiro Shiihara et al. · 2021 · Biochemical and Biophysical Research Communications
42. Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer
    Thomas B. Davis, Shilpa Gupta, Mingli Yang, Lance T. Pflieger, Malini Rajan, Heiman Wang, Ramya Thota, Timothy Joseph Yeatman, Warren Jack Pledger · 2022 · Cancers
43. The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
    Carlotta Antoniotti, Elena Ongaro, Alfredo Falcone, Chiara Cremolini · 2018 · International Journal of Molecular Sciences
44. Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonates
    Doretta Cuffaro, Linda Di Gregorio, Camilla Mangini, Martina Taglieri, Serena Matis, Roberto Benelli, Massimo Ardy, Laura Salvini, Armando Rossello, Alessandro Delli Poggi et al. · 2025 · Scientific Reports
45. Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
    Tabassom Mohajershojai, Douglas Spangler, Saloni Chopra, Fredrik Y. Frejd, Paul J. Yazaki, Marika Nestor · 2023 · Cancers
46. Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
    Federica Galvagno, Valeria Leuci, Annamaria Massa, Chiara Donini, Ramona Rotolo, Sonia Capellero, Alessia Proment, Letizia Vitali, Andrea Maria Lombardi, Valentina Tuninetti et al. · 2024 · Cancer Immunology Immunotherapy
47. Inhibition of Proliferation and Induction of Apoptosis by Gamma‐ or Delta‐Tocotrienols in Human Colorectal Carcinoma Cells
    Ali Qusay Khalid, Saatheeyavaane Bhuvanendran, Kasthuri Bai Magalingam, Premdass Ramdas, Ammu Kutty Radhakrishnan · 2025 · BioMed Research International
48. Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer
    Mary Schmitt · 2020 · Clinical journal of oncology nursing
49. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer in vitro under Cisplatin Treatment
    Przemysław Kieszkowski, Dariusz Dąbruś, Beniamin Oskar Grabarek, Dariusz Boroń · 2020 · Current Pharmaceutical Biotechnology
50. Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer
    Manuela Porru, Pasquale Zizza, Nadia Panera, Anna Alisi, Annamaria Biroccio, Carlo Leonetti · 2020 · Cancers
51. Fusobacterium nucleatum facilitates cetuximab resistance in colorectal cancer via the PI3K/AKT and JAK/STAT3 pathways
    Hu Han, Yan Li, Wan Qin, Lu Wang, Han Yin, Beibei Su, Xianglin Yuan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
52. Evaluation of the Use of Cell Lines in Studies of Selenium-Dependent Glutathione Peroxidase 2 (GPX2) Involvement in Colorectal Cancer
    Robert Steven Esworthy · 2024 · Preprints.org
53. Fusobacterium nucleatum produces previously unappreciated AHR-activating metabolites and promotes CRC cell proliferation via the AHR-TERT axis
    Kyoung‐Jae Won, Pei-Ru Jin, Lydia Davis, Jimmy Orjala, Abigail T. Armstrong, Wen- Hung Wang, Harish Kothandaraman, Sagar M. Utturkar, Dawon Bae, Byeong‐Seon Jeong et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
54. Efficiency of Escherichia coli and Bacillus subtilis Expression Systems for Production of Binase Mutants
    Alsu I. Nadyrova, Alexander S. Kosnyrev, Ульянова Вера Владимировна, Дудкина Елена Владимировна, Vershinina Vi, Olga N. Ilinskaya · 2023 · Molecular Biology
55. Mutation Rate Evolution Drives Immune Escape In Mismatch Repair-Deficient Cancer
    Hamzeh Kayhanian, Panagiotis Barmpoutis, Eszter Lakatos, William C. H. Cross, Giulio Caravagna, Luis Zapata, Kevin Litchfield, Christopher D. Steele, William Waddingham, Dominic Patel et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
56. Pan-cancer analysis of the transcriptional expression of histone acetylation enzymes in solid tumors defines a new classification scheme for gliomas
    Junhao Zhang, Lingbo Li, Aiwei Tang, Chucheng Wang, Yupeng Wang, Yongqi Hu, Guangting He, Wangjun Liao, Rui Zhou · 2025 · Frontiers in Immunology
57. Clonal dispersal is associated with tumor heterogeneity and poor prognosis in colorectal cancer
    Selami Bağlamış, Vivek M. Sheraton, Sanne M. van Neerven, Adrian Logiantara, Lisanne E. Nijman, Laura A. Hageman, Nicolas Léveillé, Clara C. Elbers, Maarten F. Bijlsma, Louis Vermeulen et al. · 2025 · iScience
58. Common gene mutations in 103 authenticated colorectal cancer cell lines
    C. Kranjec, I. Eilertsen, Luís Nunes, Seyed H Moosavi, K. Berg, M. Eknæs, M. Hektoen, B. Niederdorfer, G. Lind, R. Skotheim et al. · 2026 · Oncogenesis
59. Age-Stratified Transcriptomic Profiling Identifies CEMIP as a Candidate Biomarker in Early-Onset Colorectal Cancer and Reveals an Association with PTCH1-Related Hedgehog Signaling
    Chung‐Ying Lee, Hsu-Jui Pan, Yu‐Cheng Lee, Hieu Duc Nguyen, Yi-Chun Ni, Ke Xin Yee, Man thi Nguyen, Yung-Fu Wu, Kuen‐Haur Lee · 2026 · Genes
60. COLORECTAL MOLECULAR SUBTYPES – PROGRESS OR DEADLOCK?
    M. Yu. Fedyanin, E.O. Ignatova, А.А. Tryakin · 2021 · Practical oncology
61. Luciferase Expressing Preclinical Model Systems Representing the Different Molecular Subtypes of Colorectal Cancer
    Arne Rotermund, Martin Sebastian Staege, Sarah Brandt, Jana Luetzkendorf, Henrike Lucas, Lutz Peter Mueller, Thomas Mueller · 2023 · Cancers
62. Efficiency of Escherichia coli and Bacillus subtilis Expression Systems for Production of Binase Mutants
    Alsu I. Nadyrova, Alexander S. Kosnyrev, Ульянова Вера Владимировна, Дудкина Елена Владимировна, Vershinina Vi, Olga N. Ilinskaya · 2023 · Molecular Biology
63. Evaluation of the Use of Cell Lines in Studies of Selenium-Dependent Glutathione Peroxidase 2 (GPX2) Involvement in Colorectal Cancer
    Robert Steven Esworthy · 2024 · Diseases
64. Understand the acquired resistance of RTK inhibitors by computational receptor tyrosine kinases network
    Yuanxin Tian, Yunci Ma, Shaoyu Wu, Tingting Zhang, Zhonghuang Li, Guangfa Wang, Jiajie Zhang · 2018 · Computational Biology and Chemistry
65. Pharmacological inhibition of the ALK axis elicits therapeutic potential in Consensus Molecular Subtype 1 colon cancer patients
    Martina Mazzeschi, Michela Sgarzi, Donatella Romaniello, Valerio Gelfo, Carola Cavallo, Spartaco Santi, Michelangelo Fiorentino, Gabriele D’Uva, Balázs Győrffy, Ruth Helen Palmer et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
66. The oncogenic function of PLAGL2 is mediated via specific target genes through a Wnt-independent mechanism in colorectal cancer
    Anthony D. Fischer, Daniel Veronese-Paniagua, Shriya Swaminathan, Hajime Kashima, Deborah C. Rubin, Blair Madison · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
67. Modeling Normal and Disordered Human
    Hematopoiesis A. Beer, Connie J. Eaves · 2015
68. Optimising Oncolytic Virotherapy and Immunotherapy for the treatment of Disseminated Colorectal Cancer
    Adam Peckham-Cooper · 2017 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
69. Back-of-the-Envelope Guide (A Tutorial) to 10 Intracellular Landscapes
    Maurice HT Ling · 2018 · MOJ Proteomics & Bioinformatics
70. Insulin-Like Peptide 5 (INSL5) ☆
    Sheng Yu Ang, Roger J. Summers · 2018 · Elsevier eBooks
71. Strategies for targeting energy metabolism in Kirsten rat sarcoma viral oncogene homolog ‐mutant colorectal cancer
    Gang Wang, Junjie Wang, Peihao Yin, Ke Xu, Yu‐Zhu Wang, Feng Shi, Jing Gao, Xingli Fu · 2018 · Journal of Cellular Biochemistry
72. Drug-induced colorectal cancer persister cells show increased mutation rate
    Mariangela Russo, Simone Pompei, Alberto Sogari, Mattia Corigliano, Giovanni Crisafulli, Andrea Bertotti, Marco Gherardi, Federica Di Nicolantonio, Alberto Bardelli, Marco Cosentino Lagomarsino · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
73. Faculty Opinions recommendation of Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells.
    Lucio Comai · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
74. Faculty Opinions recommendation of Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells.
    Junjie Chen · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
75. Deep Phosphoproteomic Elucidation of Metformin-Signaling in Heterogenous Colorectal Cancer Cells
    Barbora Šalovská, Erli Gao, Sophia Müller‐Dott, Wenxue Li, Aurélien J. F. Dugourd, George Rosenberger, Julio Sáez-Rodríguez, Yansheng Liu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
76. Multi-omics Analysis Identifying CD58 Plays Important Role on Prognosis of Colorectal Cancer
    Xuan Wang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
77. Data from Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer
    Adam Lafferty, Alice C. O’Farrell, Giorgia Migliardi, Niraj Khemka, Andreas Ulrich Lindner, Francesco Paolo Sassi, Eugenia Rosalinda Zanella, Manuela Salvucci, Evy Vanderheyden, Elodie Modave et al. · 2023
78. Data from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
    Erika Durinikova, Nicole Megan Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M.L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba et al. · 2023
79. Data from Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer
    Adam Lafferty, Alice C. O’Farrell, Giorgia Migliardi, Niraj Khemka, Andreas Ulrich Lindner, Francesco Paolo Sassi, Eugenia Rosalinda Zanella, Manuela Salvucci, Evy Vanderheyden, Elodie Modave et al. · 2023
80. Data from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
    Erika Durinikova, Nicole Megan Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M.L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba et al. · 2023
81. A dual-function microfluidic chip for single-cell monoclonal antibody affinity screening and functional screening
    Jiyu Xi, Zewen Wei, Zixi Li, Zhanhui Geng · 2024 · International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB)
82. Additional file 6 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
83. Additional file 1 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
84. Additional file 3 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
85. Additional file 7 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
86. Additional file 5 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
87. Additional file 4 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
88. Establishment of a novel small bowel adenocarcinoma cell line using patient‑derived xenografts, which produces CEA and CA19‑9
    Yuri Nishioka, Yasunori Matsumoto, Kentaro Murakami, Satoshi Endo, Takeshi Toyozumi, Ryota Otsuka, Tadashi Shiraishi, Shinichiro Iida, Hiroki Morishita, Tenshi Makiyama et al. · 2024 · Oncology Letters
89. Wnt2 Expression in Cancer-Associated Fibroblasts Precedes Lymph Node Metastasis in Orthotopic Transplantation Mouse Model of Colorectal Cancer
    Hideaki Karasawa, Keigo Murakami, Koh Miura, Hiroyuki Sasaki, Tomoyuki Ono, Taiki Kajiwara, Akihiro Yamamura, Takashi Kamei, Shinobu Ohnuma, Toru Furukawa et al. · 2025 · The Tohoku Journal of Experimental Medicine
90. Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development
    Silvan Hofmann, Claudine Egger, Silke Potthast, Martin Zoche, Andreas N. WICKI, Tarun Mehra · 2025 · Frontiers in Oncology
91. Ascorbate induces G2/M arrest and necrosis without generation of direct DNA double-strand breaks
    Mehran Hariri, Eleftherios Papalanis, Diana Spiegelberg, Evgenii V. Plotnikov, Kristina Viktorsson, Bo Stenerlöw · 2025 · Heliyon
92. Additional file 1 of The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
    Martina Mazzeschi, Michela Sgarzi, Donatella Romaniello, Valerio Gelfo, Carola Cavallo, Francesca Ambrosi, Alessandra Morselli, Carmen Miano, Noemi Laprovitera, Cinzia Girone et al. · 2022 · Figshare
93. Additional file 6 of Evaluating the transcriptional fidelity of cancer models
    Da Peng, Rachel Gleyzer, Tai, Wen-Hsin, Pavithra Kumar, Qin Bian, Bradley Isaacs, Edroaldo Lummertz da Rocha, Stephanie Cai, Kathleen T. DiNapoli, Franklin W. Huang et al. · 2021 · Figshare
94. Additional file 2 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
    Deepak Vangala, Swetlana Ladigan, Sven Thorsten Liffers, Soha Noseir, Abdelouahid Maghnouj, Götze, Tina-Maria, Berlinda Verdoodt, Susanne Klein‐Scory, Laura Godfrey, Martina K. Zowada et al. · 2021 · Figshare
95. Additional file 2 of The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
    Margherita Pergolizzi, Laura Bizzozero, Federica Maione, Elena Maldi, Claudio Isella, Marco Macagno, Elisa Mariella, Alberto Bardelli, Enzo Médico, Caterina Marchiò et al. · 2022 · Figshare
96. Additional file 15 of The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
    Margherita Pergolizzi, Laura Bizzozero, Federica Maione, Elena Maldi, Claudio Isella, Marco Macagno, Elisa Mariella, Alberto Bardelli, Enzo Médico, Caterina Marchiò et al. · 2022 · Figshare
97. Additional file 6 of The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
    Margherita Pergolizzi, Laura Bizzozero, Federica Maione, Elena Maldi, Claudio Isella, Marco Macagno, Elisa Mariella, Alberto Bardelli, Enzo Médico, Caterina Marchiò et al. · 2022 · Figshare
98. Additional file 1 of Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration
    Jean Bastin, Marine Sroussi, Ivan Nemazanyy, Pierre Laurent‐Puig, Sophie Mouillet‐Richard, Fatima Djouadi · 2023 · Figshare
99. Additional file 7 of The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
    Margherita Pergolizzi, Laura Bizzozero, Federica Maione, Elena Maldi, Claudio Isella, Marco Macagno, Elisa Mariella, Alberto Bardelli, Enzo Médico, Caterina Marchiò et al. · 2022 · Figshare
100. Classification moléculaire des cancers colorectaux : corrélation anatomo cliniques et implications pronostiques
     Ralyath Balogoun · 2019